Walgreens Boots Alliance Inc (WBA) : Arvest Bank Trust Division reduced its stake in Walgreens Boots Alliance Inc by 0.48% during the most recent quarter end. The investment management company now holds a total of 94,497 shares of Walgreens Boots Alliance Inc which is valued at $7,548,420 after selling 454 shares in Walgreens Boots Alliance Inc , the firm said in a disclosure report filed with the SEC on Oct 7, 2016.Walgreens Boots Alliance Inc makes up approximately 0.64% of Arvest Bank Trust Division’s portfolio.
Other Hedge Funds, Including , Simplex Trading sold out all of its stake in WBA during the most recent quarter. The investment firm sold 3,545 shares of WBA which is valued $283,175.New England Research Management reduced its stake in WBA by selling 200 shares or 4.91% in the most recent quarter. The Hedge Fund company now holds 3,875 shares of WBA which is valued at $311,976. Walgreens Boots Alliance Inc makes up approx 0.26% of New England Research Management’s portfolio.Chevy Chase Trust Holdings reduced its stake in WBA by selling 27,048 shares or 3.53% in the most recent quarter. The Hedge Fund company now holds 739,517 shares of WBA which is valued at $59,538,514. Walgreens Boots Alliance Inc makes up approx 0.33% of Chevy Chase Trust Holdings’s portfolio.Telemus Capital reduced its stake in WBA by selling 2,496 shares or 17.89% in the most recent quarter. The Hedge Fund company now holds 11,459 shares of WBA which is valued at $922,564. Walgreens Boots Alliance Inc makes up approx 0.10% of Telemus Capital’s portfolio.Bath Savings Trust Co reduced its stake in WBA by selling 470 shares or 0.85% in the most recent quarter. The Hedge Fund company now holds 54,640 shares of WBA which is valued at $4,399,066. Walgreens Boots Alliance Inc makes up approx 1.39% of Bath Savings Trust Co’s portfolio.
Walgreens Boots Alliance Inc closed down -0.42 points or -0.52% at $79.88 with 28,51,713 shares getting traded on Friday. Post opening the session at $80.65, the shares hit an intraday low of $79.25 and an intraday high of $80.75 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Company shares were Reiterated by Deutsche Bank on Aug 30, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $93 .
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.